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Introduction 
Evidence from scores of observational studies from 
many parts of the world have demonstrated an asso-
ciation between elevated blood total homocysteine 
levels and the risk of cardiovascular disease, periph-
eral vascular disease, and stroke {l,2}. These condi-
tions are more prevalent in males than in females in 
virtually all populations studied, and their prevalence 
increases with advancing age. A much smaller body of 
data exists that describes an increasing tendency to 
higher homocysteine levels with increasing age. 
There have been no previous reports of blood 
homocysteine levels measured in a cross-sectional 
sample throughout the age spectrum from child-
hood through the elderly. However, the Third 
National Health and Nutrition Examination Survey 
(NHANES III) in the United States provides such a 
representative sample. We present here the results of 
the homocysteine analyses on 10,000 samples of se-
rum representing ages 12 years to 100 years in both 
males and females. 
The Third National Health and 
Nutrition Examination Survey 
(NHANES III): 1988-1994 
The U.S. National Center for Health Statistics has 
conducted six health examination surveys of the U.S. 
population since 1960, and has recently completed 
NHANES III {3}. The surveys are designed to obtain 
nationally representative information about the 
health and nutrition status of American populations 
through interviews and direct physical examinations. 
Physical examinations are employed because the in-
formation collected either cannot be furnished or is 
not available in a standardized manner through inter-
views with the people themselves or through records 
maintained by health professionals who provide their 
medical care. 
The goals of NHANES III are: (1) to estimate 
the national prevalence of selected disease and 
risk factors, (2) to provide national population 
reference distributions of selected health parameters, 
(3) to document and investigate reasons for secular 
trends and selected diseases and risk factors, (4) to 
contribute to an understanding of disease etiology, 
and (5) to investigate the natural history of selected 
diseases. 
The eligible population for this NHANES III is 
the U.S. civilian noninstitutionalized population ages 
2 months or older {4}. The sample design utilizes a 
stratified multistage probability sample of counties, 
blocks, and persons randomly selected from house-
holds. The periods from 1988-1991 and 1991-1994 
each constitute national samples of the U.S. popula-
tion as well as all six years combined. Eighty-one 
counties were selected from 26 states, from which 
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approximately 40,000 persons were selected and 
30,000 agreed to participate. In the period from 
1988-1991 (Phase I), 20,277 persons were selected 
for the sample. Of those, 17,464 were interviewed 
and 15,630 (77%) have participated in the Examina-
tion. Precise estimates of health characteristics are 
needed for specific subgroups of the population (chil-
dren <5 years, persons 60 years and older, black 
Americans and Mexican Americans) and these groups 
TABLE 25-1. Sampling 
subdomains by race and age: NHANES III 
Mexican-
Mrican-American White and all other American 
2-35 months 2-11 months 2-35 months 
12-35 months 
3-5 years 3-5 years 3-5 years 
6-11 years 6-11 years 6-11 years 
12-19 years 12-19 years 12-19 years 
20-39 years 20-29 years 20-29 years 
30-39 years 
40-59 years 40-49 years 40-49 years 
50-59 years 
60 years and over 60-69 years 60 years and 
70-79 years over 
80 years and over 
TABLE 25-2. Diseases studied in NHANES III 
heart disease 
asthma, chronic 
bronchitis, emphysema 
diabetes 
kidney disease and other 
urologic disorders 
gall bladder disease 
osteoporosis 
arthritis 
infectious disease 
dental caries and periodontal 
disease 
allergies 
depression 
hearing loss 
vision problems 
iron-deficiency anemia 
obesity 
TABLE 25-3. Nutrition assessment in NHANES III 
Dietary/nutrient intake 
Anthropometric measutments 
Nutritional biochemistries and hematologic tests 
Physical examination 
Interview 
are being selected in greater numbers than would 
have occurred without oversampling. 
NHANES III data collection began in the fall of 
1988 and was completed in the fall of 1994. Over the 
6-year survey, more than 36,000 persons were inter-
viewed, and more than 30,000 completed a stan-
dardized detailed physical examination in specially 
equipped mobile examination centers that traversed 
the country. The survey was conducted in two con-
secutive 3-year phases and designed so that each phase 
was a national probability sample. Table 25-1 pre-
sents the sampling scheme for NHANES III, which 
was designed to enroll a minimum of 560 individuals 
in each of the 52 sex, race, and age strata. Serum 
samples for the determination of homocysteine were 
derived from Phase II of this survey. We have already 
received all samples for participants aged 12 and 
older, and measured homocysteine concentrations on 
samples from 1,981 men and 2,401 women to date. 
When completed, we anticipate that homocysteine 
values will be available for greater than 10,000 survey 
participants ages 12 through 100 years. We also 
plan to determine homocysteine levels on approxi-
mately 3,000 samples from participants aged 3 to 11 
years. 
The data collected in this survey will be used to 
estimate the prevalence of major diseases and nutri-
tion disorders, as well as potential risk factors. 
NHANES III data will also be the basis for national 
standards that measure height,. weight, and blood 
pressure. Data from NHANES III will be used in 
epidemiologic and health science research to direct 
and design health programs and services and expand 
the health knowledge for the nation. 
As in the past Health Examination Surveys, data 
from NHANES III will describe the prevalence of 
chronic conditions in the population, data on previ-
ously undiagnosed conditions, and those known to 
and reported by the survey respondent. The diseases 
TABLE 25-4. Nutritional biochemistry analysis 
in NHANES III 
Retionl and retinyl esters 
Carotene profile 
Selenium 
Calcium, total and ionized 
Vitamin A, vitamin C, vitamin D, vitamin E 
Serum iron: total iron binding capacity 
Serum ferritin and protoporphyrin 
Serum and red cell folate 
Serum homocysteine 
Serum methylmalonic acid 
Vitamin B12 
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and medical conditions to be studied are included in 
table 25-2. Table 25-3 lists the methods and proce-
dures used to assess nutritional status. Table 25-4 
lists the nutritional biochemical measures used to 
assess micronutrient status in this survey. 
Serum Homocysteine in NHANES III 
Having serum homocysteine analyses available from a 
large representative sample of U.S. population (n = 
15,000, age ~ than 3) with an oversampling for eld-
erly and minority groups, a complete physical exami-
nation, hematology, serum and urinary biochemical 
data, anthropometry/body composition, dietary data, 
and information on supplement use, etc., provides a 
remarkable opportunity for analysis. Blood was drawn 
on participants whose fasting status was variable but 
recorded. Whole blood was held at room temperature 
for 30-60 minutes prior to centrifugation. Sera were 
separated and frozen at -20°C and transferred 
to the Centers for Disease Control and Prevention's 
central laboratory for priority analyses. Some 
samples went through numerous freeze cycles. 
After priority analyses were complete, the surplus sera 
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were held at -70°C for periods ranging from eight 
months to 3 years before they were analyzed for 
homocysteine. 
Homocysteine measurements were carried out at 
the USDA Human Nutrition Research Center on 
Aging using the method of Araki and Sato [5}. The 
preliminary results presented here are based on a 
sample of 1,981 males and 2,401 females aged 12-
102 years. The mean age for both men and women 
was 43.8 years. The age-adjusted geometric mean 
homocysteine concentrations for men and women 
were 9.8 and 8.0~mollL respectively (fig. 25-1). 
Homocysteine concentrations increased continuously 
with age for men and women, and were greater for 
men at all ages (fig. 25-2). In men, geometric mean 
concentrations increased by 63% across the age range 
presented here, from 7. 7 ~mol/L at ages 12-19 years 
to 12.4~mol/L in the 85+-year-old age group. For 
women, geometric mean homocysteine concentra-
tions increased 75%, from 6.4 to 11.2 ~mollL across 
the ages considered here. 
There was a significant age-sex interaction (p < 
0.001), indicating that the age relations differed in 
men and women. The age-related increase in 
~ 
~ 
25 30 35 40 4S 50 55 60 
Serum Homocysteine 
FIGURE 25-1. Distribution of serum homocysteine concen-
trations in 1981 men (-) and 2401 women (-), ages 12 to 
102 years: Preliminary results from NHANES III. 
(umoVL) 
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homocysteine appeared to be continuous and gradual 
in men except for an abrupt 23% increase between 
the 12-19 and 20-29 year-old age groups. This re-
sulted in a more than 30% higher concentration in 
men than in women, a difference that was largely 
sustained until women approached the age of 50. At 
this age, concentrations in women appear to increase 
more rapidly with age than those in men, sub-
stantially reducing the sex-related difference in 
homocysteine concentrations to approximately 12% 
by ages 60-69 years, a relative difference that is main-
tained over the next two decades of life. 
Our results are consistent with observations from 
other large samples. The Hordaland Homocysteine 
Srudy [6} examined 7,591 men and 8,585 women 
ages 40-67 years with no history of vascular disease, 
diabetes, or hypertension. In the youngest partici-
pants (ages 40-42), homocysteine concentrations in 
men were 19% greater than those in women. This 
difference diminished to 11 % in the oldest age group 
considered (65-67 years). Homocysteine concentra-
tions increased 13% in men and 21 % in women from 
age 40-42 years to age 65-67 years. Brattstrom and 
colleagues [7} examined a much smaller sample of 
131 men and 113 women across a broader age range 
(35-95 years). They also observed that men had 
higher homocysteine concentrations than women at 
every age. In the youngest age groups (35-49 years), 
concentrations in men exceeded those in women by 
11 %; in the oldest age group (80-95 years) these 
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FIGURE 25-2. Geometric mean of serum homocysteine 
concentrations and 95 % confidence intervals by age decade 
in 1981 men (circles) and 2401 women (squares): Prelimi-
nary data results from NHANES III. 
concentrations were 9% greater in men. In men, a 
steady increase in homocysteine over the age groups 
resulted in a 60% greater homocysteine concentration 
in the men ages 80-95 years compared with those 
who were 35-49 years old. In contrast, concentra-
tions in women did not appear to increase until ap-
proximately age 65 years, when they demonstrated an 
approximately 20% increase. By age 80, the concen-
trations in women, just as in men and similar to what 
we report here, had risen approximately 60% from 
the youngest age group considered. 
Using data from the original Framingham cohort 
who were 67-96 years of age, we previously reported 
[8} that homocysteine concentrations were 10% 
higher in men than in women under age 75 years of 
age, and that the sex difference was reduced in the 
older age groups. We also reported that homocysteine 
concentrations continued to increase across this 
range of older ages. We observed a 20% increase in 
homocysteine in this older cohort even across the 
fairly narrow (29-year) age range. Much of this in-
crease was seen for those subjects over age 80. We 
have also noted very similar age and sex relations with 
homocysteine in the Framingham Offspring cohort, 
in which we have collected data on men and women 
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ages 26-83 years (unpublished observations), and in 
these preliminary NHANES III data. 
Although the analyses of NHANES III 
homocysteine data in relation to nutrient intake, 
blood folate levels, and measures of vitamin B12 status 
are yet to be made, and the associations with measures 
of renal function have not yet been performed, 
this rich body of information awaits analysis in asso-
ciation with a variety of nutrition diseases and 
anthropometric variables. In the absence of any of 
these other analyses, it would be prematute to specu-
late on the mechanism of this increase in blood 
homocysteine throughout the age spectrum, or on the 
consistent gender difference of males always being 
higher. 
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